Study #2021-1031
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Piflufolastat F18
Description
To learn if piflufolastat F18 can be used in imaging scans for patients with breast cancer, HCC, or pancreatic cancer
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Pancreatic Cancer, Breast Cancer, Hepatocellular Carcinoma
Study phase:
Phase I
Physician name:
Yang Lu
Department:
Nuclear Medicine
For general questions about clinical trials:
1-855-575-6618
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.